StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

CNBX Pharmaceuticals's total assets was $12.80K at May 31, 2026. For fiscal 2025 it was $18.44K, down 41.3% from the year before. Over ten years it grew -4.3% a year on average. The highest annual figure on record is $15.18M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Aug 31, 2025$18.44K-41.3%
FY2024Aug 31, 2024$31.38K-93.7%
FY2023Aug 31, 2023$499.04K-38.5%
FY2022Aug 31, 2022$811.17K-73.7%
FY2021Aug 31, 2021$3.08M+38.7%
FY2020Aug 31, 2020$2.22M-85.4%
FY2019Aug 31, 2019$15.18M+376.7%
FY2018Aug 31, 2018$3.18M-12.4%
FY2017Aug 31, 2017$3.64M+15238.8%
FY2016Aug 31, 2016$23.72K-17.4%
FY2015Aug 31, 2015$28.70K-74.9%
FY2014Aug 31, 2014$114.22K+57.0%
FY2013Aug 31, 2013$72.76K-23.4%
FY2010Aug 31, 2010$94.96K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026May 31, 2026$12.80K-31.3%
Q2 FY2026CQ1 2026Feb 28, 2026$14.90K-70.6%
Q1 FY2026CQ4 2025Nov 30, 2025$11.16K-50.0%
Q4 FY2025CQ3 2025Aug 31, 2025$18.44K-41.3%
Q3 FY2025CQ2 2025May 31, 2025$18.62K-76.7%
Q2 FY2025CQ1 2025Feb 28, 2025$50.66K-69.1%
Q1 FY2025CQ4 2024Nov 30, 2024$22.31K-94.2%
Q4 FY2024CQ3 2024Aug 31, 2024$31.38K-93.7%
Q3 FY2024CQ2 2024May 31, 2024$80.03K-87.9%
Q2 FY2024CQ1 2024Feb 29, 2024$163.92K-64.5%
Q1 FY2024CQ4 2023Nov 30, 2023$387.40K-36.4%
Q4 FY2023CQ3 2023Aug 31, 2023$499.04K-38.5%
Q3 FY2023CQ2 2023May 31, 2023$662.02K-31.4%
Q2 FY2023CQ1 2023Feb 28, 2023$462.05K-59.4%
Q1 FY2023CQ4 2022Nov 30, 2022$609.51K-71.3%
Q4 FY2022CQ3 2022Aug 31, 2022$811.17K-73.7%
Q3 FY2022CQ2 2022May 31, 2022$965.74K-74.6%
Q2 FY2022CQ1 2022Feb 28, 2022$1.14M-77.1%
Q1 FY2022CQ4 2021Nov 30, 2021$2.12M+24.8%
Q4 FY2021CQ3 2021Aug 31, 2021$3.08M+38.7%
Q3 FY2021CQ2 2021May 31, 2021$3.80M-31.2%
Q2 FY2021CQ1 2021Feb 28, 2021$4.97M+39.1%
Q1 FY2021CQ4 2020Nov 30, 2020$1.70M-73.7%
Q4 FY2020CQ3 2020Aug 31, 2020$2.22M-85.4%
Q3 FY2020CQ2 2020May 31, 2020$5.53M-72.0%
Q2 FY2020CQ1 2020Feb 29, 2020$3.57M-80.5%
Q1 FY2020CQ4 2019Nov 30, 2019$6.46M-31.9%
Q4 FY2019CQ3 2019Aug 31, 2019$15.18M+376.7%
Q3 FY2019CQ2 2019May 31, 2019$19.77M+525.7%
Q2 FY2019CQ1 2019Feb 28, 2019$18.34M+392.8%
Q1 FY2019CQ4 2018Nov 30, 2018$9.48M+209.7%
Q4 FY2018CQ3 2018Aug 31, 2018$3.18M-12.4%
Q3 FY2018CQ2 2018May 31, 2018$3.16M-8.8%
Q2 FY2018CQ1 2018Feb 28, 2018$3.72M+529.2%
Q1 FY2018CQ4 2017Nov 30, 2017$3.06M+982.0%
Q4 FY2017CQ3 2017Aug 31, 2017$3.64M+15238.8%
Q3 FY2017CQ2 2017May 31, 2017$3.46M–
Q2 FY2017CQ1 2017Feb 28, 2017$591.64K–
Q1 FY2017CQ4 2016Nov 30, 2016$282.96K–
Q4 FY2016CQ3 2016Aug 31, 2016$23.72K–

More CNBX Pharmaceuticals figures

See a number that looks wrong?